ICH to implement M14 Guideline for post-marketing safety submissions
By Catherine Eckford (European Pharmaceutical Review)
Pharma’s UK dissatisfaction mounts as Merck & Co axes $1.3bn expansion
By Dominic Tyer (European Pharmaceutical Review)
Obesity drug competition fuels Novo Nordisk restructure
By Catherine Eckford (European Pharmaceutical Review)
FDA approves first-of-a-kind intravesical drug delivery system for bladder cancer
By Catherine Eckford (European Pharmaceutical Review)
Amid FDA turmoil Sarepta’s gene therapy worries begin to ease
By Dominic Tyer (European Pharmaceutical Review)